Copyright Reuters
Wegovy's highest dose of 2.4 mg will now cost 16,400 rupees ($186.59), compared with its earlier price of 24,389.06 rupees. Its lowest dose of 0.25 mg will sell at 10,850 rupees, compared with 16,260.94 rupees earlier. Sign up here. Novo Nordisk did not immediately respond to a request seeking comment. ($1 = 87.8950 Indian rupees) Reporting by Rishika Sadam; Editing by Dhanya Skariachan and Anil D'Silva Our Standards: The Thomson Reuters Trust Principles., opens new tab Rishika leads Reuters’ coverage of India’s pharmaceutical and healthcare sector. Her reporting focuses on key themes such as the emergence of weight-loss drugs, the country’s drug regulatory framework and manufacturing quality standards, and developments shaping India’s pharmaceutical exports to major markets including the United States and Europe. She also covers the country’s rapidly growing hospital industry. With nearly a decade of experience in journalism, Rishika has previously reported extensively on Indian politics, national elections, and on social affairs and criminal justice.
